CHEWING GUM REDUCES HPV AND ORAL CANCER-ASSOCIATED BACTERIA IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Emerging data published in Scientific Reports, demonstrates extracts from a bioengineered chewing gum to significantly reduce the levels of 3 microbes associated with head and neck squamous cell carcinoma (HNSCC). The medicated chewing gum displayed substantial reductions in oral human papillomavirus (HPV), Porphyromonas gingivalis (P gingivalis), and Fusobacterium nucleatum (Fnucleatum). The research evaluated a lablab […]
LINDA RATHBUN’S STORY
“I had always been able to handle the physical demands of my jobs and hobbies, but over the years, I started to experience some annoying symptoms: coughing, acid reflux, and weird sensations in my throat. I saw many doctors to try to get my symptoms under control and figure out what was causing them. I […]
Current status and perspective of immunotherapy for head and neck squamous cell carcinoma
Current status and perspective of immunotherapy for head and neck squamous cell carcinoma Introduction: Head and neck squamous cell carcinoma (HNSCC), has still a high mortality rate even if several multimodal treatments have been developed in the advanced stages. Areas covered: In recent years, immunotherapy was introduced for the treatment of advanced and metastatic HNSCC […]
HEAD AND NECK SQUAMOUS CELL CARCINOMA
Squamous cell carcinoma is a cancer that arises from cells called squamous cells. The strongest risk factors are: tobacco alcohol consumption infection of human papillomavirus (HPV) Early diagnosis can save your live! Listen 👆 and share
A New Era of Immunotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
The standard of care for locally advanced HNSCC has remained unchanged for decades. However, 2 landmark studies presented at the 2025 ASCO Annual Meeting may signal a pivotal shift in the management of locally advanced, resectable HNSCC. Key Points: The standard of care for locally advanced head and neck squamous cell carcinoma (HNSCC) has remained […]
Comparison of PD-L1 expression in head and neck squamous cell carcinoma among preoperative biopsy, surgical resection and metastatic lymph node
Comparison of PD-L1 expression in head and neck squamous cell carcinoma among preoperative biopsy, surgical resection and metastatic lymph node Background: The interpretation of PD-L1 expression in advanced head and neck squamous cell carcinoma (HNSCC) has recently emerged as a component of companion diagnostics, essential in identifying candidates for immune checkpoint inhibitors (ICIs). However, evaluating […]
T CELL DYNAMICS WITH NEOADJUVANT IMMUNOTHERAPY IN HEAD AND NECK CANCER
T CELL DYNAMICS WITH NEOADJUVANT IMMUNOTHERAPY IN HEAD AND NECK CANCER Neoadjuvant immune-checkpoint inhibitors (ICIs) have been shown to be safe with promising early trial results in patients with locally advanced, resectable human papillomavirus-unrelated head and neck squamous cell carcinoma. Immune-checkpoint inhibitors (ICIs) are being tested as neoadjuvant therapies in various solid tumours, including in […]
HALLMARKS OF CANCERS OF THE NOSE AND SINUSES
HALLMARKS OF CANCERS OF THE NOSE AND SINUSES Cancers of the #nose and #sinuses squamous cell carcinoma are rare; about 2,000 people develop these cancers every year. Do you want to know more? Read the slides and share